| Dr Richard Donald Groves, DDS | |
|
1 Overlook Dr, Suite A 3, Amherst, NH 03031-2800 | |
| (603) 673-4102 | |
| Not Available |
| Full Name | Dr Richard Donald Groves |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 1 Overlook Dr, Amherst, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689621831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 1853 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Donald Groves, DDS 1 Overlook Dr, Suite A 3, Amherst, NH 03031-2800 Ph: (603) 673-4102 | Dr Richard Donald Groves, DDS 1 Overlook Dr, Suite A 3, Amherst, NH 03031-2800 Ph: (603) 673-4102 |
News Archive
Four student-led community engagement projects will be awarded the 2009-10 AACP Student Community Engaged Service Award for their outstanding programs delivering consumer education about medication use, expanding access to affordable healthcare and improving the public's health.
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
The diets of hunter-gatherers are changing at a fast pace, as in the contemporary world, they are increasingly being deprived of their access to land and natural resources and urged to adapt to sedentary lifestyle.
Learning the secrets of how pathogenic bacteria manage to survive in the body of an animal or human may carry great implications for future development of new and better medical treatments. Now, scientists at the University of Maryland School of Dentistry have unraveled one important secret of bacterial adaptation.
GlaxoSmithKline and XenoPort, Inc. (Nasdaq: XNPT) today announced that the U.S. Food and Drug Administration (FDA) has extended the original Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) for GSK1838262/XP13512 (gabapentin enacarbil) to February 9, 2010. The original PDUFA date for this NDA review was November 9, 2009.
› Verified 6 days ago
Malvika Singh, DMD Dentist Medicare: Medicare Enrolled Practice Location: 131 Nh 101a Ste 1, Amherst, NH 03031 Phone: 866-589-4713 | |
Dr. Kenneth George Edwards, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 109 Ponemah Rd, Suite A, Amherst, NH 03031 Phone: 603-673-0782 Fax: 603-673-4747 | |
Bernard W Ang, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1 Limbo Ln, Amherst, NH 03031 Phone: 603-673-5510 | |
Dr. Shivani H Patel, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 71 Route 101a, Amherst, NH 03031 Phone: 603-672-6546 | |
Dr. David L Patten, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1 Limbo Ln, Amherst, NH 03031 Phone: 603-673-5510 | |
Andrew Todd Cheifetz, DMD MED Dentist Medicare: Not Enrolled in Medicare Practice Location: 7 Route 101a, Colonial Park Suite D, Amherst, NH 03031 Phone: 603-673-1000 Fax: 603-673-2422 | |
Dr. Stephen J. Clark, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 102 Ponemah Rd, Amherst, NH 03031 Phone: 603-673-7950 Fax: 603-672-7647 |